AUSPEX PHARMACEUTICALS INC Inactive Instrument
Company Auspex Pharmaceuticals Inc
Equities
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2015 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 2015 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 57 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rod A. Ferguson
BRD | Director/Board Member | 67 | 12-12-31 |
Alex Zisson
BRD | Director/Board Member | 54 | 13-10-16 |
Sep Sarshar
FOU | Founder | 57 | 01-02-27 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 32,439,897 | 25,606,628 ( 78.94 %) | 624,710 ( 1.926 %) | 78.94 % |
Company contact information
Auspex Pharmaceuticals, Inc.
3366 North Torrey Pines Court Suite 400
92037, San Diego
+858 558 2400
http://www.auspexpharma.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -2.26% | 104B | |
| +1.41% | 97.42B | |
| +0.79% | 22.2B | |
| -17.84% | 21.23B | |
| -11.11% | 18.33B | |
| -42.83% | 16.35B | |
| -17.63% | 15.06B | |
| +4.55% | 13.98B | |
| +32.11% | 11.66B |
- Stock Market
- Equities
- Stock
- Company Auspex Pharmaceuticals Inc
